Although a Y specific growth gene(s) has been postulated in the Yqll region, the precise location has not been determined. To localise the growth gene(s), we correlated genotype with stature in 13 Japanese and four European non-mosaic adult male patients with a partial Yq deletion. Fourteen patients preserving the region between DYSll and DYS246 did not have short stature (11 Japanese, 165-180 cm; three Europeans, 165-173 cm) whereas the remaining three patients with the region deleted had short stature (two Japanese, both 159 cm; one European, 157 cm). The results suggest that the region defined by DYS1I at interval 5C and by DYS246 at interval SD may be the critical region for the Y specific growth gene(s). 
The Y chromosome carries a Y specific growth gene(s) that significantly augments adult height independently of the effect of gonadal sex steroids. This hypothesis is primarily based on the white adult height comparisons between patients with pure XY gonadal dysgenesis and those with pure XX gonadal dysgenesis (172.0 (SD 7.0) cm, n=24 v 164.3 (SD 7.7) cm, n= 22, p<0.01), between patients with complete testicular feminisation syndrome and normal females (172.2 (SD 6.5)cm, n=23, v 162.2 (SD 6.0) cm, British standard, p<0.01), and between normal males and XX males (174.7 (SD 6.7) cm, British standard v 166.4 (SD 7.4) cm, n = 33, p<0.01)."2 In the three comparisons, the sex chromosome complement is different but the effect of bioactive gonadal sex steroids is comparable. Furthermore, on the basis of the adult height differences indicated by the three comparisons, it has been assumed that the Y specific growth gene(s) increases the adult height by 8-10 cm and thus accounts for about two-thirds of the sex difference in mean adult height (about 13 cm).`-The remaining adult height difference between sexes has been explained by the notion that testicular androgens have the potential to increase adult height by 3-5 cm while ovarian oestrogens have no major effect on adult height. '-3 The Y specific growth gene(s) has been assigned to Yqll, proximal In this paper, we attempt to localise the Y specific growth gene(s) on the basis of genotype-phenotype correlations in patients with Yq -chromosomes.
Methods

SELECTION OF PATIENTS
The patients analysed in the present study were collected from a large series ofinfertile Japanese males ascertained from 1988 to 1993. The selection criteria used were: (1) measurement of height between 20 and 50 years of age; (2) lack of associated disorders or therapeutic interventions that may affect stature; (3) absence of demonstrable mosaicism; (4) lack of autosomal or X chromosomal abnormalities; (5) confirmation of a partial Yq deletion by molecular studies; and (6) 
(1--N00000000<:000c0 000 0000001C~m 13 (fig 4) . In addition, the proximal breakpoint in case 17 was found to be between DYS271 and DYZ3.
The screening of the Y chromosomal YAC contig with four probes defining Yq loci assigned DYS140 to interval 5C (between DYS 11 and DYS273), DYS 139 to interval 5G (between DYS 136 and DYS279), DYS 134 to interval 5K (distal to STSP), and DYS 132 to interval 50 (distal to STSP) (fig 2) (data not shown).
Discussion
The present study suggests that the region between DYSI1 at interval 5C and DYS246 at interval 5D may be the critical region for the Y specific growth gene(s) (fig 2) . All of the 14 patients with Yq -chromosomes preserving the critical region were free from short stature (cases 1 to 11 and cases 14 to 16), and all the three patients with Yq -chromosomes missing the critical region had short stature (cases 12, 13, and 17). Although the short stature in the three cases could also be partly accounted for by growth disadvantage resulting from chromosome imbalance,' it appears unlikely that the short stature is totally attributable to this: case 11 was normal in height in the presence of chromosome imbalance similar to that of the three cases. Rather, the coexistence of chromosome imbalance may explain why the degree of short stature in the three cases is apparently greater than the estimated deletional effect of the Y specific growth gene(s) (8 to 10 cm). Interestingly, the critical region consists of Y specific single copy DNA sequences rather than of X homologous or Y specific repetitive DNA sequences. ' Despite the above caveats, our results offer the first clue to the cloning of the Y specific growth gene(s). In summary, although genotype-phenotype analysis of the Y specific growth gene(s) is still not conclusive, we propose that the Y specific growth gene(s) may be present in the critical region defined by DYS 1 1 and DYS246. Further accumulation of in- DYZ 3 formative patients will permit a more precise 4-170 bp localisation. 
